Today, the U.S. House of Representatives passed H.R. 3, the so-called Lower Drug Costs Now Act of 2019. Representative Mike Kelly (R-Pa.) voted against the bill and issued the following statement:
"Congressional action to address the prescription drug affordability crisis should be about people, not politics. While Democrats may have scored a few cheap political points with their socialist base by passing H.R. 3, they did nothing to help Americans who increasingly struggle to afford their medications. This government price-fixing scheme would lead to the development of fewer new cures and reduce access to existing life-saving drugs. We should focus our efforts on policy that will work and can pass such as H.R. 19, a bipartisan alternative to H.R. 3 that won't threaten medical innovation."
Representative Kelly also spoke against H.R. 3 on the floor of the House during debate on the evening of December 11. Video below.